Novo Nordisk A/S ADR buy gerihouse
Start price
04.04.24
/
90%
€117.00
Target price
04.04.25
€140.00
Performance (%)
-52.91%
End price
05.04.25
€55.10
Summary
This prediction ended on 05.04.25 with a price of €55.10. Massive losses of -52.91% were the result for the BUY prediction by gerihouse. Dividends of €1.56 are taken into consideration when calculating the performance. gerihouse has 90% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | 9.102% | 9.102% | -38.739% |
| iShares Core DAX® | 0,99 % | 8,31 % | 7,03 % |
| iShares Nasdaq 100 | 2,07 % | 16,77 % | 35,95 % |
| iShares Nikkei 225® | 2,27 % | 15,61 % | 46,57 % |
| iShares S&P 500 | 1,04 % | 11,08 % | 26,46 % |
According to gerihouse what are the pros and cons of Novo Nordisk A/S ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
Small cyclical dependencies
Known brand
Cons
Comments by gerihouse for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Buy mit Kursziel 140,0
In the thread Trading Novo Nordisk A/S ADR
Die von gerihouse gewählte maximale Laufzeit wurde überschritten
Stopped prediction by gerihouse for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€42.39
30.08.16
30.08.16
€50.00
02.02.17
02.02.17
-25.03%
02.02.17
02.02.17
Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
Small cyclical dependencies
